Increasing Prevalence Of Cardiovascular Diseases Is Fueling The Market Growth Due To Rising Demand For Vascular And Anti-Inflammatory Therapies Is Supporting Development Across The Autacoids And Related Drug Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Autacoids And Related Drug Market Through 2030?

The autacoids and related drug market has experienced substantial growth in recent years. This market is set to expand from $52.81 billion in 2025 to $55.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. The expansion observed in prior periods can be attributed to several factors including the prevalence of inflammatory diseases, the rising incidence of allergies, the burden posed by cardiovascular disorders, new treatments for gastrointestinal conditions, and the ongoing development of hospital pharmacology.

The autacoids and related drug market is anticipated to show strong growth over the next few years. It is projected to expand to $70.07 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.8%. This growth during the forecast period can be attributed to the adoption of precision pharmacology, the development of receptor-targeted drugs, the increasing management of chronic diseases, the expansion of outpatient treatment, and the use of combination therapies. Key trends during this period include the broadening application in inflammatory disease management, an intensified focus on receptor-specific drug action, a rising demand for targeted autacoid modulators, increasing utilization in cardiovascular and respiratory care, and greater adoption of combination therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

Which Drivers Are Advancing The Autacoids And Related Drug Market Growth?

The growing incidence of cardiovascular diseases is anticipated to spur the expansion of the autacoids and related drugs market moving forward. These conditions represent a spectrum of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The increasing occurrence of cardiovascular diseases is primarily linked to inadequate diet, as consuming excessive saturated fats, trans fats, added sugars, and sodium leads to high blood pressure, obesity, and elevated cholesterol levels, all major risk factors for heart-related ailments. Autacoids and their associated drugs enhance cardiovascular health through the modulation of vascular tone and inflammation, which is critical in conditions like hypertension and heart failure. Agents that target pathways involving nitric oxide, endothelin, and prostacyclin contribute to restoring endothelial function, thereby promoting vasodilation and reducing vascular resistance. Illustratively, in September 2023, the World Health Organization, a Switzerland-based intergovernmental organization, reported 17.9 million deaths due to cardiovascular diseases. Thus, the escalating prevalence of cardiovascular diseases is a key driver for the growth of the autacoids and related drugs market.

How Is The Autacoids And Related Drug Market Examined Through Segment Analysis?

The autacoids and related drug market covered in this report is segmented –

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin

2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation

3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders

4) By End User: Hospitals, Clinics, Homecare, Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists

2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs

3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors

4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators

5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

Which Trends Are Shaping The Autacoids And Related Drug Market Landscape?

Major companies involved in autacoids and related drugs are prioritizing the development of innovative products, such as antihistamines, to boost therapeutic efficacy, decrease side effects, and precisely and safely tackle emerging allergic and inflammatory conditions. Antihistamines are medications designed to block the effects of histamine, a chemical the immune system releases during an allergic reaction. For instance, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceuticals company, launched Bilastine as an over-the-counter (OTC) medicine in Germany. This action marked a significant progression in improving access to effective allergy treatments. The Bilastine 20 mg tablets offer a non-sedating, second-generation antihistamine solution for patients experiencing allergic symptoms such as hay fever and urticaria.

Which Key Players Are Active In The Autacoids And Related Drug Market?

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy’s Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

Access The Complete Autacoids And Related Drug Market Report:

https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report

Which Region Is The Dominant Market In The Autacoids And Related Drug Market?

North America was the largest region in the autacoids and related drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Autacoids And Related Drug Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

Browse Through More Reports Similar to the Global Autacoids And Related Drug Market 2026, By The Business Research Company

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Antacids Market Report 2026

https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795